Stockreport

Nektar down 9% on release of Phase 1/2 data on NKTR-214 [Seeking Alpha]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF Nektar down 9% on release of Phase 1/2 data on NKTR-214Nektar Therapeutics (NKTR-9%) is down in light volume in early trade in response to the release of abstracts for A [Read more]